Extended Data Table 1.

Treatment efficacy by combination regimen: durvalumab-ceralasertib versus durvalumab plus olaparib, danvatirsen or oleclumab

Analyses by individual cohort are provided in Extended Data Table 2 and Supplementary Tables 3–5.